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Soluble Adenylyl Cyclase Defines a Nuclear cAMP
Microdomain in Keratinocyte Hyperproliferative
Skin Diseases
Jonathan H. Zippin1, Paul A. Chadwick2, Lonny R. Levin3, Jochen Buck3 and Cynthia M. Magro2
Cyclic adenosine monophosphate (cAMP) is a nearly ubiquitous signaling molecule important for numerous
signaling pathways in human skin. We studied a novel class of mammalian adenylyl cyclase, the soluble adenylyl
cyclase (sAC). We examined sAC localization in normal human skin and found it to be present in keratinocytes,
melanocytes, mononuclear cells, eccrine ducts, and nerves. In normal skin, sAC keratinocyte staining was
evenly distributed throughout the cell. However, in certain hyperproliferative disorders of the skin, including
psoriasis, verruca vulgaris, and SCCIS on sun-damaged skin, sAC keratinocyte staining was predominantly
nuclear. In contrast, in other hyperproliferative disorders, such as basal cell carcinoma, sAC staining was similar
to normal human skin. Using a model of epithelial differentiation, we established that sAC migrates into the
nucleus when differentiated cells are induced to reenter the cell cycle. Previous work had determined that
nuclear sAC activates the cAMP-response-element-binding (CREB) transcription factor, and we found that in
psoriasis lesions, nuclear sAC occurs concomitantly with activation of CREB. Hence, sAC may play a role in the
pathogenesis of certain hyperproliferative skin disorders via modulation of gene expression.
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INTRODUCTION
Epidermal hyperplasia can occur secondary to a number of
stimuli. These stimuli can be separated into congenital
genetic alterations, infectious, inflammatory, and cell-cycle/
apoptotic dysregulation as seen within the spectrum of
epidermolytic hyperkeratosis, human papilloma virus
(HPV), psoriasis, and skin cancer, respectively. Although
each of these skin diseases is induced by a varied set of
stimuli, they all are defined by the proliferation of keratino-
cytes. Keratinocyte proliferation requires alteration in pro-
grammed differentiation along with induction of the cell
cycle. Cellular differentiation and cell cycle are modulated
by numerous signaling pathways, and hyperstimulation or
dysregulation of these pathways represents key events leading
to many diseases of epidermal hyperplasia. The cyclic
adenosine monophosphate (cAMP)-signaling pathway is
integral to both cellular differentiation and proliferation,
and has been implicated in the pathogenesis of diseases of
epidermal hyperplasia such as psoriasis (Yoshikawa et al.,
1975; Wadskov et al., 1979; Adachi et al., 1980; Voorhees,
1982; Grandjean-Laquerriere et al., 2005).
The signaling molecule cAMP has long been studied
in the epidermis. cAMP and its effector proteins, such
as protein kinase-A (PKA) and cAMP-response-element-
binding protein (CREB), have known roles in the cells of the
epidermis and dermis, including keratinocytes, melanocytes,
eccrine ductal cells, and fibroblasts (Slominski et al., 2006).
In many cases the initiating stimulus for these cAMP-
dependent pathways are well established; for example,
the melanocyte-stimulating hormone-induced cAMP path-
ways in melanocytes (Abdel-Malek et al., 2008). In other
cases, the stimuli leading to cAMP signal transduction are
less clear.
Mammalian cells contain two distinct classes of adenylyl
cyclase, the transmembrane adenylyl cyclases (tmACs) and
soluble adenylyl cyclase (sAC) (Buck et al., 1999). tmACs are
more widely studied and are exclusively expressed at the
plasma membrane. sAC, unlike tmACs, is not exclusively
expressed at the plasma membrane, but instead is found in
the cytoplasm, at the mitochondria, at the centriole, and
within the nucleus (Zippin et al., 2003, 2004; Feng et al.,
2005, 2006).
Because cAMP has an integral role in the proliferation,
differentiation, and expression of key proteins in keratino-
cytes, we examined the expression and localization of sAC
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protein in normal human skin and disease. We found that
sAC is upregulated in the nuclei of keratinocytes in certain
hyperproliferative skin diseases, including psoriasis and
squamous cell carcinoma (SCC) in situ. Interestingly, sAC
is lost from the nucleus when a malignant epithelial tumor
acquires invasive properties in the dermis. We have
previously demonstrated that nuclear sAC is associated with
the activated cAMP-dependent transcription factor CREB, and
have found this trend to also exist in human psoriasis lesions.
These data shed light on the complexity of cAMP signaling
in skin disease and suggest sAC might represent a key player
in the pathogenesis of hyperproliferative skin diseases.
RESULTS
Examination of sAC immunostaining in normal human skin
Using a previously described mouse monoclonal antibody
against human sAC protein (Zippin et al., 2003, 2004), we
examined sAC expression in normal human skin. sAC was
present in multiple cell types within both epidermis and
dermis (Figure 1a–f). All specific staining was absent if
primary antibody was either incubated with blocking peptide
(Figure 1c) or omitted (data not shown). In the epidermis,
sAC was strongly expressed in keratinocytes (Figure 1b).
Staining appeared evenly distributed throughout the cell,
without specific localization. There were occasional cells
with nuclear staining, but these cells represented a minority
of the total keratinocytes. sAC was absent in the cornified
cell layer. sAC protein was also present in melanocytes as
confirmed by costaining with Melan-A (Figure 1d). sAC
was present in a variety of mononuclear cells in the dermis
(Figure 1b). Co-staining with different markers, such as CD3,
CD20, CD1a, and CD56, established that these cells consisted
of T-cells, macrophages, and dendritic cells (data not shown).
sAC was also present in eccrine duct cells (Figure 1e).
In addition, we found sAC protein in cutaneous nerve axons
as confirmed by co-staining with PGP9.5 (Figure 1f).
Figure 1. Immunostaining of sAC in normal skin. (a) Hematoxylin (blue) and eosin (red) staining of normal human skin. (b) Normal human skin immunostained with
R21 (red) and hematoxylin (blue). (c) Normal human skin immunostained with R21þ blocking peptide (red) and hematoxylin (blue). (d) Normal epidermis
immunostained with R21 (red), Melan-A (brown), and hematoxylin (blue). (e) Normal human skin eccrine duct immunostained with R21 (red) and hematoxylin
(blue). (f) Normal human skin cutaneous nerve immunostained with R21 (red), PGP9.5 (brown), and hematoxylin (blue). Bars¼ 50mm (a–c) and 10mm (d–f).
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Examination of sAC immunostaining in common viral infections
of the epidermis
In most lesions of verruca vulgaris (Figure 2a–c and Table 1),
sAC cytoplasmic staining was significantly reduced as
compared with normal epidermis (Figure 1b), and instead
sAC was predominately nuclear throughout the lesion. As
in normal epidermis, staining was mainly undetectable in
the cornified layer. sAC was not exclusively present in the
nucleus. While some cells had strong nuclear staining
(Figure 2c, gray arrow), other nuclei had no sAC staining
(Figure 2c, black arrow). In contrast to HPV-induced skin
lesions, molluscum contagiosum virus (MCV) infection
did not induce a predominance of sAC nuclear staining
(Figure 2d–f and Table 1). In fact, it was rare to see a nucleus
positive for sAC staining. Instead, sAC staining was granular
in quality and perinuclear in localization (Figure 2f).
Figure 2. Immunostaining of sAC in viral infections of the epidermis. (a) Hematoxylin (blue) and eosin (red) staining of a verruca vulgaris skin lesion.
(b) Verruca vulgaris skin lesion immunostained with R21 (red) and hematoxylin (blue). (c) Verruca vulgaris skin lesion immunostained with R21 (red) and
hematoxylin (blue). The black arrow demonstrates a nucleus negative for sAC. The gray arrow demonstrates a nucleus postive for sAC. (d) Hematoxylin
(blue) and eosin (red) staining of a molluscum contagiosum skin lesion. (e) Molluscum contagiosum skin lesion immunostained with R21 (red) and hematoxylin
(blue). (f) Molluscum contagiosum skin lesion immunostained with R21 (red) and hematoxylin (blue). Bars¼ 100mm (a, b, d, e) and 10mm (c, f).
Table 1. Degree of nuclear sAC staining in examples of keratinocyte hyperproliferative skin disease
Expression pattern
+ +/ 
Verruca vulgaris 6 0 3
Molluscum contagiosum 0 0 7
Seborrheic keratosis 6 1 3
Epidermolytic hyperkeratosis 0 0 4
Acanthosis nigricans 0 3 2
Actinic keratosis 4 1 0
Bowenoid papulosis with high-grade dysplasia, +HPV in situ 1 3 7
Squamous cell carcinoma in situ, no dermal involvement, sun-exposed sites 9 1 3
Squamous cell carcinoma, invasion of dermis, both sun-exposed and non-exposed sites 3 1 2
Basal cell carcinoma 0 0 10
Pityriasis rubra pilaris 0 1 2
Psoriasis vulgaris 5 5 0
Psoriasis pustular 3 0 0
Psoriasis guttate 4 0 0
Abbreviation: sAC, soluble adenylyl cyclase.
: Approximately 10% of keratinocytes have nuclei positive for sAC and sAC staining is strongly cytoplasmic (equivalent to normal skin); +/: 10–70% of
keratinocytes have nuclei positive for sAC and decreased cytoplasmic sAC staining in keratinocytes with sAC nuclear staining; +: 470% of keratinocytes
have nuclei positive for sAC, with barely detectable cytoplasmic sAC staining.
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In vitro epithelial cell model of differentiation
There are key differences between the pathogenesis of HPV
and MCV. HPV is known to exert its pathological effects on
the epidermis mainly by inducing keratinocyte proliferation
and entry of cells into S-phase of mitosis. Proliferation and
host DNA synthesis are key since this virus replicates in the
nucleus and requires the host DNA polymerase to synthesize
new viral genomes (Tyring, 2000). MCV, like all pox viruses,
replicates in the cytoplasm because its genome encodes for
a viral DNA polymerase (Brown et al., 1981) and, therefore, it
does not require the cell to enter the cell cycle to replicate.
Because of this difference in viral pathogenesis between HPV
and MCV, we hypothesized that sAC nuclear staining occurs
in tandem with entry into the cell cycle.
Madin–Darby canine kidney (MDCK) cells (Figure 3),
Caco-2 human colonic cells (data not shown), and human
retinal pigment epithelial cells (data not shown) represent
three of the best-characterized models of epithelial differen-
tiation (Foerg et al., 2007). When these cell lines are grown to
confluence, cellular division stops and cells develop tight
junctions and other markers of epithelial differentiation.
Eventually, these cells form the functional sheets of polarized
epithelial cells. Once fully differentiated, sAC staining in the
epithelial-like cells was exclusively within the cytoplasm of
MDCK (Figure 3a, middle panel), Caco-2 (data not shown),
and retinal pigment epithelial cells (data not shown). A key
feature of these cell models is that differentiation is not
permanent; simple removal of cellular contacts induces the
cells to de-differentiate and resume proliferation. There are
two established methods for disrupting cell-to-cell contacts of
the epithelial sheets: clearing a line of cells by scraping with a
metal spatula (sometimes referred to as wounding) or by
simple trypsinization. After wounding (data not shown) or
trypsinization (Figure 3b), sAC nuclear staining returned in
MDCK (Figure 3b, middle panel), Caco-2 (data not shown),
and retinal pigment epithelial cells (data not shown).
Examination of sAC immunostaining in UV-induced
keratinocyte neoplasms
UV radiation is capable of inducing both benign and
malignant neoplasms of the epidermis. Seborrheic keratoses
are benign neoplasms; the exact genetic mutations remain
unknown (Noiles and Vender, 2008). In the majority
of seborrheic keratoses examined (see Supplementary Figure
S1 online and Table 1), sAC staining was predominately
nuclear, with a relatively decreased level of cytoplasmic
staining as compared with normal skin (Figure 1b).
Actinic keratosis (AK), SCC in situ (SCCIS), and invasive
SCC can be considered as a continuum of increasing patho-
genecity. All three neoplasms occur secondary to UV-
induced DNA damage and in most cases are typified by
mutations in p53 (Criscione et al., 2009). In AKs, sAC staining
was enriched in the nucleus and significantly decreased in
the cytoplasm (Figure 4a and b, inset and Table 1). Nearly all
SCCIS cases examined had a similar sAC staining pattern to
AKs; that is, sAC was enriched in the nucleus and was
relatively decreased in the cytoplasm as compared with
normal skin (Figure 4c and d, inset and Table 1). sAC staining
in invasive SCC revealed a more mosaic pattern. Approxi-
mately 50% of SCC samples examined (Table 1), regardless
of subtype, had strong nuclear sAC staining in the SCCIS
component, but no nuclear sAC staining in the invasive
component (Figure 4e and f). In fact, in some of these SCC
cases the invasive component was devoid of all sAC staining.
The remaining SCC cases retained a predominant nuclear
sAC staining pattern, with a relatively decreased cytoplasmic
staining intensity (Figure 4g and h, and Table 1).
Compared with SCC, basal cell carcinoma demonstrated a
very different sAC immunostaining pattern. sAC staining was
virtually absent from all nuclei; the frequency of nuclear
staining was equivalent to the frequency in normal skin. sAC
staining in BCC was intense and diffusely cytosolic, and this
pattern was identical among all basal cells carcinomas
Figure 3. sAC is present in the nucleus when epithelial cells are proliferating and not when epithelial cells are differentiating. (a) Differentiated MDCK
cells stained with DAPI (left), anti-N-term sAC antibody (center), and overlay of DAPI and anti-N-term (right). (b) Proliferating undifferentiated MDCK cells
stained with DAPI (left), anti-N-term sAC antibody (center), and overlay of DAPI and anti-N-term (right). Bar¼ 10 mm.
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Figure 4. Immunostaining of sAC in AK and SCC. (a) Hematoxylin (red) and eosin (blue) staining of AK. (b) AK immunostained with R21 (red) and hematoxylin
(blue); inset, magnified view of the area in panel b. (c) Hematoxylin (red) and eosin (blue) staining of SCCIS. (d) SCCIS immunostained with R21 (red) and
hematoxylin (blue); inset, magnified view of the area in panel d. (e) Hematoxylin (red) and eosin (blue) staining of SCC. (f) SCC immunostained with R21 (red) and
hematoxylin (blue). (g) Hematoxylin (red) and eosin (blue) staining of SCC. (h) SCC immunostained with R21 (red) and hematoxylin (blue). Bars¼50mm.
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analyzed regardless of pathologic subtype (Supplementary
Figure S2a–c and Table 1). Of all the epidermal diseases
examined in this study, sAC localization in BCC most closely
resembled that in normal skin.
Examination of sAC immunostaining in virally induced
malignant neoplasms
Although the vast majority of HPV infections develop into
benign growths, a few HPV subtypes, namely 16, 18, 31, and
33, cause high-grade squamous proliferative lesions in the
skin ranging from bowenoid papulosis to frank carcinoma
(Jablonska and Majewski, 1999). If the viral genome inte-
grates into the host chromosome, viral production stops and
large amounts of viral E6 and E7 proteins are expressed,
inducing the destruction of the tumor suppressor p53(Tyring,
2000). Histologically, lesions of bowenoid papulosis are
nearly identical to SCCIS; however, from a clinical pers-
pective they resemble common venereal warts and do not
develop invasive properties; in most cases, although there
are rare reports of invasion (Jablonska and Majewski,
1999). Although these neoplasms are caused by HPV
infection, sAC localization in high-risk HPV infections did
not match sAC localization in low-risk HPV infections
(Figure 2a–c). Instead, sAC localization was absent from the
nucleus and present in a perinuclear granular staining pattern
(Supplementary Figure S2d–f).
Examination of sAC immunostaining in benign inflammatory
proliferations of the epidermis
We found consistent sAC staining pattern in a variety of
human psoriasis cases, including at least five examples
of guttate, plaque-type, and pustular psoriasis (Table 1).
Among all forms of psoriasis, within the area of epidermal
thickening, sAC staining changed from predominately cyto-
plasmic (Figure 1b) to a distribution where sAC protein was
almost exclusively nuclear (Figure 5b, inset, white arrow).
sAC was not present in all nuclei (Figure 5b, inset, black
arrow), nor did sAC expression extend into the area of
parakeratosis.
Pityriasis rubra pilaris is another disease of keratinocyte
proliferation. Although its exact pathophysiological mechan-
ism is not known, it is believed to occur secondary to an
antigen-triggered immune response such as streptococcal
infection (Mohrenschlager and Abeck, 2002). Unlike psoriasis,
sAC staining in pityriasis rubra pilaris biopsies was predomi-
nately cytoplasmic, with little to no increase in nuclear
staining (Table 1 and data not shown).
In psoriasis, nuclear sAC is associated with activated cAMP
effector proteins
cAMP-dependent gene expression, mediated by the trans-
cription factor CREB, is known to occur in psoriatic keratino-
cytes (Funding et al., 2007), and we previously demonstrated
that nuclear sAC is capable of activating CREB by inducing
a PKA-dependent phosphorylation (Zippin et al., 2004).
We hypothesized that in cells with increased level of nuclear
sAC, there would also be increased level of activated
CREB. Staining psoriasis skin samples with an antibody that
recognizes the phosphorylated (ie, activated) form of CREB
demonstrated that a large number of keratinocyte nuclei were
positive for phosphoCREB, and that the majority of keratino-
cytes that contain high levels of active CREB also contain
high levels of nuclear sAC (Figure 5c).
DISCUSSION
sAC is a newly described signaling molecule, which is
capable of regulating a variety of cellular processes such as
apoptosis (Kumar et al., 2009), gene expression (Zippin et al.,
2004), neutrophil activation (Han et al., 2005), and sperm
motility (Hess et al., 2005). We examined the localization of
sAC in normal human skin and found the protein to be
diffusely expressed in keratinocytes and melanocytes of the
epidermis, eccrine ductal cells, mononuclear cells, and
cutaneous nerves. sAC staining in eccrine ductal cells is
particularly interesting because of the established locali-
zation and physiology of sAC in kidney and epididymis
(Pastor-Soler et al., 2003; Paunescu et al., 2008; Brown et al.,
2009), and similarities in physiology between eccrine ducts,
kidney, and epididymis (Granger et al., 2002). In kidney and
epididymis, sAC associates with and stimulates proton flux
through vacuolar–ATPases (V-ATPase), which are integral to
pH regulation of these organs (Pastor-Soler et al., 2003;
Paunescu et al., 2008). V-ATPases are also present in eccrine
ductal cells where they are important for the proper secretion
Figure 5. Nuclear sAC is enhanced in psoriatic skin and is associated with phosphorylated CREB. (a) Hematoxylin (red) and eosin (blue) staining of psoriatic lesional
skin. (b) Psoriatic lesional skin immunostained with R21 (red) and hematoxylin (blue). The inset is a magnified view of a portion of the epidermis demonstrating
that some nuclei are positive for sAC (white arrow) and some are negative for sAC (black arrow). (c) Psoriatic lesional skin immunostained with R21 (red) and an
antibody against phosphorylated CREB (light blue). Panel c and inset: Nuclei positive for both sAC and phosphorylated CREB appear dark blue to purple (gray arrows).
White arrows indicate nuclei positive for phosphorylated CREB only (light blue). Black arrows indicate nuclei positive for sAC only (red). Bars¼50mm.
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of sweat (Granger et al., 2002). It would be interesting
to determine whether sAC activity is involved in sweat
production in mammals. The observed cutaneous nerve
staining is also interesting given that previous reports have
demonstrated the presence of sAC in dorsal root ganglion
cells of the rat and its involvement in axonal guidance
(Wu et al., 2006).
Nuclear sAC staining has been observed in mammalian
liver (Zippin et al., 2004). sAC staining was not present in
all nuclei, but instead was detected in the nucleus of a
small subset of hepatocytes where it was hypothesized to
reflect the turnover of individual hepatocytes. In this study,
we confirmed this staining pattern in normal skin, and have
established that sAC is nuclear during cellular proliferation
and is absent from the nucleus when cells differentiate. As the
skin loses dead cells from the cornified layer, new cells are
replaced from below. In normal skin, cell division occurs
both at the basal cell layer and immediately above the basal
cell layer, which consists of a group of cells called transient
amplifying cells (Iizuka et al., 2004). Consistent with this
fact, we find sAC nuclear staining in normal skin to occur
primarily in the lower levels of the epidermis (Figure 1).
While basal cell layer stem cells can divide forever, their rate
of division is very slow compared with that of transient
amplifying cells, which have a finite proliferative potential.
In psoriasis, the transient amplifying cell layer is thought
to represent the group of keratinocytes, which respond to
inflammatory cytokines and lead to skin lesions (Iizuka et al.,
2004). Therefore, one would expect to detect the majority
of sAC nuclear staining above the basal cell layer in
psoriasis, and consistent with this hypothesis, we found the
strongest sAC nuclear staining in psoriasis lesions in a band
of keratinocytes above the basal cell layer and below the
upper layers of the epidermis where cells are beginning to
differentiate (Figure 5b).
We previously demonstrated that when sAC is nuclear it
stimulates the phosphorylation and activation of the CREB
transcription factor. We have also shown that in mammalian
tissues, such as the liver, when sAC is present in the nucleus,
CREB protein tends to be phosphorylated, and when sAC is
absent from the nucleus, CREB tends to not be phosphory-
lated (Zippin et al., 2004). In this report, we confirmed
the association between nuclear sAC and active CREB in
psoriasis skin lesions. CREB activity in keratinocytes has
been recently linked to psoriasis pathogenesis. Recent
studies have found increased level of phosphorylated CREB
in both psoriatic epidermis and in psoriatic keratinocytes in
culture (Funding et al., 2007). Although T-cells and the
immune system clearly have an important role in the
pathogenesis of psoriasis, recent work has demonstrated
that alteration in the expression of key keratinocyte
transcription factors, c-Jun and JunB, is sufficient to induce
psoriasis-like effects in mice (Zenz et al., 2005). Keratinocyte
c-Jun and JunB are both regulated by CREB and are
upregulated in psoriatic lesional skin as compared with
perilesional normal skin, suggesting a role for keratinocyte
cAMP signaling in psoriasis pathogenesis (Zenz and Wagner,
2006).
Although there are many reports suggesting a role for
cAMP signaling in psoriasis pathogenesis, this area of
research remains a topic of debate. Most of the debate stems
from conflicting data regarding cAMP signaling in psoriatic
keratinocytes. Whereas some laboratories have recorded
elevation of adenylyl cyclase activity and cAMP levels in
psoriasis, others report a decrease (Yoshikawa et al., 1975;
Wadskov et al., 1979; Adachi et al., 1980; Voorhees, 1982).
In addition, other groups have found highly decreased
binding of cAMP to PKA in erythrocytes membranes, which
was specific for active psoriasis (Raynaud et al., 1989; Schopf
et al., 2002). Of note, all of these studies were performed
with reagents, which activate or inhibit only the tmAC class
of mammalian adenylyl cyclases; therefore, the role of sAC in
psoriasis pathogenesis has not been fully examined. Follow-
ing the discovery and characterization of sAC, our laboratory
has generated a cadre of reagents, which distinguish between
sAC- and tmAC-generated cAMP. We have used these
reagents both in vivo and in vitro to determine the relative
contribution of each class of cyclase in physiological path-
ways such as insulin release, mitochondrial respiration
(Acin-Perez et al., 2009), nerve cell migration (Wu et al.,
2006), and kidney ion channel regulation (Paunescu et al.,
2008). We intend to readdress the role of cAMP in the patho-
genesis of psoriasis both in vivo and in vitro using reagents
that can distinguish between tmAC- and sAC-generated
cAMP.
Aside from inducing DNA mutation, UV radiation, via a
cAMP-dependent mechanism, alters the cytokine expression
profile of keratinocytes leading to local immune suppression,
a risk factor for development of a skin cancer (Grandjean-
Laquerriere et al., 2003, 2005). Studies examining UV-
induced cytokine expression in keratinocytes are particularly
interesting because these data clearly demonstrate that the
effects of UV radiation are PKA-dependent; however, the
source of cAMP mediating these effects remains elusive
(Grandjean-Laquerriere et al., 2005). Nuclear sAC is induced
in UV-dependent neoplasms and likely leads to activation of
CREB. It would be interesting to determine whether sAC
might be a source of cAMP responsible for UV-induced PKA
activation and immune-suppressive cytokine expression.
MATERIALS AND METHODS
Antibodies
R21 and anti-N-term (produced in the Laboratory of Drs Levin and
Buck); phosphoCREB (Cell Signaling Technologies, Danvers, MA);
A103/Melan-A, CD20, and CD68 (Dako, Carpinteria, CA); CD1a
and CD56 (Novocastra, Deerfield, IL); CD3 (Neomarkers, Fremont,
CA); CD123 (BD Biosciences, San Jose, CA); and PGP9.5 (Abcam,
Cambridge, MA).
Immunohistochemistry of human tissue
Cases were retrospectively identified using archival tissue from the
database of the Division of Dermatopathology, Weill Medical
College of Cornell University. All cases were interpreted by
C Magro. The cases chosen included verruca vulgaris (9), MCV (7),
seborrheic keratosis (10), epidermolytic hyperkeratosis (4), acanthosis
nigricans (5), AKs (5), bowenoid papulosis (11), SCC both in situ
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and invasive (19), basal cell carcinoma (10), pityriais rubra pilaris (3),
and psoriasis (17). For normal skin unremarkable sections of skin
from excision specimens were chosen. Immunostaining of patient
samples was approved under IRB protocol number 0710009479,
Weill Cornell Medical Center, New York, NY. The study was
conducted according to the Declaration of Helsinki Principles.
All steps were performed using the Leica Microsystems
BondMax Autostainer (Bannockburn, IL). Formalin-fixed, paraffin-
embedded samples were first baked at 60 1C for 30minutes followed
by a dewaxing procedure. Slides were treated with a Leica
Microsystems Dewax solution (part number AR922) for 3minutes
at 72 1C, then a Dewax solution wash at 72 1C, and finally a Dewax
solution wash at ambient temperature. This was followed by three
washes with Ethyl Alcohol 200 proof (Pharmco-Aaper, Brookfield,
CT, cat. number 111000200) and three washes with Leica Micro-
systems Wash buffer (part number AR9590).
All sections were treated as follows for sAC immunostaining:
following the dewaxing procedure, the samples were pretreated by
two washes in Leica Microsystems HIER1 (part number AR9961),
followed by HIER1 pretreatment for 30minutes at 100 1C, and then
HIER1 pretreatment for 12minutes at ambient temperature. Before
immunostaining, the sections were blocked using the Dako Dual
Endogneous Enzyme Block (part number S2003) for 5minutes
followed by three washes with Bond Wash Solution. The wash
buffer (Bond Wash Solution) is used in all washing steps described
below unless otherwise noted.
R21 is a mouse monoclonal antibody directed against amino
acids 203–216 of human sACfl protein (Zippin et al., 2003). The
primary antibody (3mgml1, 1:500) was applied for 25minutes in
a buffered Primary Antibody Diluent (AR9352) from Leica Micro-
systems. Following this step the sections were treated by a post
primary AP step for 20minutes for signal amplification as part of the
procedure detailed in the Leica Microsystems Bond Polymer AP Red
Detection kit (part number DS9305). The amplification polymer was
then added for 30minutes followed by two washes in wash buffer
and one in deionized water. Finally, the mixed red substrate was
applied for 10minutes followed by an additional 10 minutes with
new substrate, three washes in deionized water only, and, finally,
mounting with coverslip.
When blocking peptide was used, the antibody was pre-diluted in
Bond Primary Antibody Diluent with and without blocking peptide
(100 molar excess) and rocked at room temperature overnight. These
pre-diluted solutions were used for immunostaining as above.
When R21 was immunostained alone, hematoxylin (part of Bond
Polymer Define Detection kit) co-stain was used to highlight the
nuclei. The stain was incubated on the slide for 5minutes followed
by one wash in 70% alcohol, three washes in 100% alcohol, two
washes in Citrasolv (Fisherbrand 22–143975), and mounting with
coverslip.
For co-staining of R21 stained sections with phosphorylated
CREB antibody (1:500) antibody, the sample was pretreated by
two washes of Leica Microsystems HIER1 (part number AR9961),
followed by HIER1 pretreatment for 30minutes at 100 1C, and then
HIER1 pretreatment for 12minutes at ambient temperature. Before
immunostaining, the sections were blocked using the Dako Dual
Endogneous Enzyme Block (part number S2003) for 5minutes.
The primary antibody was applied for 30minutes in Bond
Primary Antibody Diluent. Following this step the sections were
treated with a post primary AP step for 20minutes for signal ampli-
fication as part of the procedure detailed in the Leica Micro-
systems Bond Polymer AP Red Detection kit (part number DS9305).
The amplification polymer was then added for 30minutes followed
by three washes. Finally the Alkaline Phosphotase Substrate kit III
Vector (part number SK-5300) was applied for 10minutes followed
by an additional 10minutes with new substrate, three washes, and,
finally, mounting with coverslip.
For co-staining with Melan-A (1:50), PGP9.5 (1:2500), CD1a
(1:20), CD3 (1:100), CD20 (1:200), CD56 (1:50), CD68 (1:300), and
CD123 (1:50), following staining with R21, the samples were
blocked using the Peroxidase Block (part of the Leica Biosystems
Bond Polymer Define Detection kit, part number DS9713) for
5minutes. Sections were then pretreated in HIER2 for 20 or
30minutes and washed as above, depending on the antibody, as
per manufacturer’s instructions. This was followed by three washes
at 35 1C and one wash at ambient temperature.
The primary antibody was applied for 25minutes in Bond
Primary Antibody Diluent followed by three washes. Following this
step the sections were treated with a post primary step for 15minutes
for signal amplification as part of the procedure detailed in the Leica
Microsystems Bond Polymer Define Detection kit (part number
DS9713) followed by three washes in wash buffer. The amplification
polymer was then added for 30 minutes followed by two washes in
wash buffer and one in deionized water. Finally, the Mixed
Diaminobenzidine (DAB) Define was applied for 10minutes.
Counterstaining was accomplished by adding hematoxylin for
5minutes.
Cell culture and immunocytochemistry
MDCK cells were cultured in DMEMþ 10% fetal calf serum and
grown to confluence on glass coverslips. Confluent cultures were
fed daily over 1 week to allow complete differentiation of the cells.
At this point, some coverslips were immunostained while others
were trypsinized and split on fresh coverslips at a lower density
to induce proliferation. These cells were immunostained within
24 hours of trypsinization. For immunostaining, coverslips were
washed in phosphate-buffered saline, fixed for 30minutes in 4%
paraformaldehyde, and permeabilized in 0.1% Triton X-100, and
then blocked in 2% bovine serum albumin for at least 1 hour.
Cells were stained with anti-sAC rabbit polyclonal antibody over-
night in 2% BSA/0.01% Triton X-100, washed three times over
10minutes in 2% BSA/0.01% Triton X-100, stained for 1 hour
at room temperature with goat-anti-rabbit Alexa Fluor-488
(Molecular Probes, Eugene, OR), treated with DAPI for 5minutes,
and then washed and mounted with gelvatol/DABCO (Sigma,
St Louis, MO).
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